DOE OSTI · 21078007
Neutralizing antibodies decrease the envelope fluidity of HIV-1
Abstract
For successful penetration of HIV-1, the formation of a fusion pore may be required in order to accumulate critical numbers of fusion-activated gp41 with the help of fluidization of the plasma membrane and viral envelope. An increase in temperature to 40 {sup o}C after viral adsorption at 25 {sup o}C enhanced the infectivity by 1.4-fold. The enhanced infectivity was inhibited by an anti-CXCR4 peptide, T140, and anti-V3 monoclonal antibodies (0.5{beta} and 694/98-D) by post-attachment neutralization, but not by non-neutralizing antibodies (670-30D and 246-D) specific for the C5 of gp120 and cluster I of gp41, respectively. Anti-HLA-II and an anti-HTLV-I gp46 antibody, LAT27, neutralized the molecule-carrying HIV-1{sub C-2(MT-2)}. The anti-V3 antibodies suppressed the fluidity of the HIV-1{sub C-2} envelope, whereas the non-neutralizing antibodies did not. The anti-HLA-II antibody decreased the envelope fluidity of HIV-1{sub C-2(MT-2)}, but not that of HIV-1{sub C-2}. Therefore, fluidity suppression by these antibodies represents an important neutralization mechanism, in addition to inhibition of viral attachment.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Harada, Shinji, Monde, Kazuaki, Tanaka, Yuetsu, Kimura, Tetsuya, Maeda, Yosuke, Yusa, Keisuke. 2008-01-05. Neutralizing antibodies decrease the envelope fluidity of HIV-1. https://doi.org/10.1016/j.virol.2007.08.021. https://engineeringpapers.com/record/osti%3A21078007/neutralizing-antibodies-decrease-the-envelope-fluidity-of-hiv-1
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Engineering Papers by Indiciae: BibTeX · RIS.